Occhiuti Rohlicek & Tsao LLP
HLA alleles associated with adverse drug reactions and methods for detecting such
This invention relates to a method of determining the presence of certain HLA alleles, such as HLA-B*1502 or HLA-B*5801, and a kit for carrying out this method. Also disclosed is a method for assessing whether a patient is at risk for developing adverse drug reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis, or hypersensitivity syndrome) based on the presence or absence of a genetic marker (e.g., HLA-B*1502, HLA-B*5801, or HLA-B*4601).
Academia Sinica Pharmigene Inc.
C C Y C C C C C
C12Q C12Q Y10T C12Q C12Q C12Q C12Q C12Q
inventional additional additional additional additional inventional additional additional
Wei-Hsuan Chi-Feng Chih-Lung Hsin-Yu Shuen-Iu Yuan-Tsong
Chen Chang Shen Lin Hung Chen